Kelli Grant W. Williams M.D., MPH
Allergy and immunology; Pediatrics
Adults and pediatrics
Heather K. Lehman M.D.
Allergy and immunology; Pediatrics
Pediatrics
Natural killer cell deficiency inspires student's research
July 22, 2026
Read article
Never miss new content
Get our latest articles, podcast episodes, videos, and publications delivered directly to your inbox. Stay informed with timely insights and practical resources you can use.
Ekterly
A plasma kallikrein inhibitor indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.
Report side effects/adverse events at 1-877-825-3327 or www.fda.gov/medwatch.
KalVista
Ionis
Dawnzera
Dawnzera is a prekallikrein-directed antisense oligonucleotide indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.
Report side effects/adverse events at 1-800-FDA-1088 or www.fda.gov/medwatch.
Wiskott-Aldrich syndrome study shows carriers have symptoms
July 07, 2026
Read article
Erica Schmitt M.D., Ph.D.
Allergy and immunology; Pediatrics; Rheumatology
Pediatrics
